Coronation Fund Managers Ltd. Grows Position in Danaher Co. (NYSE:DHR)

Coronation Fund Managers Ltd. boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 29.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,389 shares of the conglomerate’s stock after acquiring an additional 1,470 shares during the period. Coronation Fund Managers Ltd.’s holdings in Danaher were worth $1,596,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Cape Investment Advisory Inc. purchased a new position in Danaher in the fourth quarter valued at about $25,000. Tsfg LLC raised its stake in shares of Danaher by 733.3% during the 1st quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 88 shares in the last quarter. Wetzel Investment Advisors Inc. purchased a new stake in Danaher during the fourth quarter valued at approximately $29,000. Redmont Wealth Advisors LLC acquired a new stake in Danaher in the first quarter valued at approximately $30,000. Finally, Rakuten Securities Inc. purchased a new position in Danaher in the fourth quarter worth $36,000. Institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DHR. Robert W. Baird raised their price objective on Danaher from $271.00 to $278.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Jefferies Financial Group assumed coverage on shares of Danaher in a research note on Monday, June 3rd. They set a “buy” rating and a $295.00 price target on the stock. Bank of America upped their target price on Danaher from $270.00 to $275.00 and gave the company a “neutral” rating in a research report on Wednesday, July 24th. The Goldman Sachs Group lifted their price target on Danaher from $225.00 to $250.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 24th. Finally, StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, June 25th. Six investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $276.88.

Danaher Price Performance

Shares of NYSE DHR traded down $0.01 during midday trading on Friday, hitting $269.32. The stock had a trading volume of 1,746,456 shares, compared to its average volume of 2,862,712. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $281.70. The company has a quick ratio of 1.04, a current ratio of 1.43 and a debt-to-equity ratio of 0.33. The stock has a 50 day simple moving average of $257.69 and a 200-day simple moving average of $253.45. The company has a market capitalization of $199.48 billion, a PE ratio of 45.65, a P/E/G ratio of 4.62 and a beta of 0.83.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 23rd. The conglomerate reported $1.72 EPS for the quarter, beating the consensus estimate of $1.57 by $0.15. The firm had revenue of $5.74 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The business’s revenue for the quarter was down 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $2.05 earnings per share. On average, sell-side analysts expect that Danaher Co. will post 7.59 EPS for the current fiscal year.

Insider Transactions at Danaher

In other Danaher news, Director Linda Filler sold 3,928 shares of Danaher stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $279.50, for a total transaction of $1,097,876.00. Following the transaction, the director now directly owns 41,149 shares of the company’s stock, valued at $11,501,145.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Danaher news, Director Linda Filler sold 3,928 shares of the firm’s stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $279.50, for a total transaction of $1,097,876.00. Following the completion of the sale, the director now owns 41,149 shares of the company’s stock, valued at $11,501,145.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Brian W. Ellis sold 9,600 shares of the company’s stock in a transaction on Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $5,566,486.80. The disclosure for this sale can be found here. Insiders have sold a total of 38,707 shares of company stock worth $10,786,944 in the last quarter. Company insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.